查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571806

先进眼科技术市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分市场预测，2024-2030 年

Advanced Ophthalmology Technology Market Size, Share & Trends Analysis Report By Type (Diagnostic, Therapeutic), By End Use (Hospitals, Ophthalmic Clinics, ASCs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格
简介目录

先进眼科技术市场成长与趋势：

预计2030年，全球先进眼科技术市场规模将达128.9亿美元，2024年至2030年复合年增长率为7.5%。光同调断层扫瞄扫描仪、镜面显微镜、准分子雷射和飞秒雷射等各种眼科设备中频繁采用先进眼科技术预计将推动整体市场的成长。

老年人口的不断增加导致白内障、糖尿病性视网膜病变和近视等与老龄化。此类眼科疾病的日益普及正在推动眼科治疗和先进眼科设备的采用。市场主要企业专注于采用先进技术，例如 SWEPT 来源 OCT、部分相干干涉测量 (PCI) 和 Polatest 技术。这些技术将有助于开发有效的眼科设备，以有效诊断和治疗眼科疾病。

眼科超音波成像系统是最受青睐的先进眼科诊断设备之一，预计将大幅成长。与眼科超音波成像系统产业相比，光学超音波测量系统产业预计在预测期内也将稳定成长。这是因为光学生物测量提供了比超音波更准确的资料，并且技术的改进有助于测量晶状体厚度、前房深度和其他眼轴长度参数。

2018年，手术设备在先进眼科治疗设备中占比最大。这是由于眼科手术的增加。主要的眼科手术器械是微型角膜刀和玻璃体视网膜手术器械。微型角膜刀主要用于LASIK和 ALK 手术。准分子雷射也是优选的先进眼科雷射之一。这是因为这些雷射在非常低的波长下产生非常小、精确的光斑。

先进眼科技术市场报告亮点

  • 由于主要市场参与者的存在、老龄化相关眼病患病率的增加以及先进眼科设备在美国的频繁核准等因素，北美在 2023 年获得了最大的市场占有率。
  • 预计诊断领域将在 2023 年占据主导市场占有率，并呈现最快的成长速度。这是由于对眼部疾病早期诊断的需求不断增加。
  • 光同调断层扫瞄扫描仪是高度首选的先进眼科诊断设备，因为它们可以透过高解析度影像提供准确的结果。
  • 治疗行业预计将呈现良好的成长率。预计眼科雷射在预测期内将以显着的速度成长。这些雷射治疗眼部疾病安全有效。
  • 由于门诊手术中心为眼科护理手术提供优惠报销，预计这些中心将呈现最快的成长速度。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章先进眼科技术市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 先进的眼科技术市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 先进眼科技术市场：类型估计与趋势分析

  • 细分仪表板
  • 先进眼科技术市场：类型变化分析，2024年及2030年
  • 诊断
  • 治疗

第五章先进眼科技术市场：最终用途估计与趋势分析

  • 细分仪表板
  • 先进眼科技术市场：最终用途变化分析，百万美元，2024-2030
  • 医院
  • 门诊手术中心
  • 眼科诊所

第六章先进眼科技术市场：区域估计与趋势分析

  • 2024年及2030年按地区分類的先进眼科技术市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Carl Zeiss Meditec AG
    • Bausch + Lomb.
    • Teva Pharmaceutical Industries Ltd.
    • CooperVision
    • Alcon
    • NIDEK CO., LTD.
    • TOPCON CORPORATION
    • Ziemer Ophthalmic Systems AG
    • Essilor International SA
简介目录
Product Code: GVR-3-68038-882-4

Advanced Ophthalmology Technology Market Growth & Trends:

The global advanced ophthalmology technology market size is expected to reach USD 12.89 billion in 2030 and is projected to grow at a CAGR of 7.5% from 2024 to 2030. Frequent introduction of advanced ophthalmology technologies incorporated in various ophthalmic devices such as optical coherence tomography scanner, specular microscopes, excimer lasers, and femtosecond lasers is expected to drive the overall market growth.

Rising geriatric population is contributing toward the growing prevalence of age-related ophthalmic disorders such as cataract, diabetic retinopathy, and myopia. This growing prevalence of ophthalmic disorders is boosting the adoption of ophthalmic treatments, and thus, advanced ophthalmic devices. Major players in the market are focusing on adopting advanced technologies such as SWEPT Source OCT, Partial coherence interferometry (PCI), and Polatest technology. These technologies will help in developing effective ophthalmic devices for efficient diagnosis and treatment of ophthalmic disorders.

Ophthalmic ultrasound imaging systems are one of the most preferred advanced ophthalmic diagnostic device and is expected to grow at a significant pace. The optical biometry systems segment is also expected to grow at steady rate during the forecast period in comparison to the ophthalmic ultrasound imaging systems segment. This is because optical biometry provides more accurate data in comparison to ultrasound as the refinements in its technology help in measuring lens thickness, anterior chamber depth, and other axial length parameters.

Surgical devices held the largest share among advanced ophthalmic therapeutic devices in 2018. This is because of the increasing number of ophthalmic surgeries. Major ophthalmic surgical devices are microkeratome and Vitreo retinal surgery devices. Microkeratome is largely preferred for LASIK and ALK surgery. Excimer lasers are also preferred as one of the advanced ophthalmic lasers because these lasers produce very small and precise spots at a very low wavelength.

Advanced Ophthalmology Technology Market Report Highlights:

  • North America captured the largest market share in 2023 owing to factors such as presence of major market players, growing prevalence of age-related ophthalmic disorders, and frequent approvals of advanced ophthalmic devices in the U.S.
  • The diagnostic segment held the dominant market share in 2023 and is expected to witness the fastest growth rate. This is because of the growing need for early diagnosis of ophthalmic disorders.
  • Optical coherence tomography scanners are highly preferred products under advanced diagnostic ophthalmic devices as these scanners provide accurate results via high resolution images.
  • The therapeutic segment is expected to showcase a lucrative growth rate. Ophthalmic lasers are expected to grow at a significant pace during the forecast period. These lasers are safe and effective in the treatment of ophthalmic disorders.
  • Ambulatory surgery centers are expected to exhibit the fastest growth rate owing to favorable reimbursement provided by these centers for ophthalmology procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Advanced Ophthalmology Technology Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Advanced Ophthalmology Technology Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Advanced Ophthalmology Technology Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Advanced Ophthalmology Technology Market: Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Diagnostic
    • 4.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutic
    • 4.4.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Advanced Ophthalmology Technology Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Advanced Ophthalmology Technology Market: End Use Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ophthalmic Clinics
    • 5.5.1. Ophthalmic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Advanced Ophthalmology Technology Market: Regional Estimates & Trend Analysis

  • 6.1. Advanced Ophthalmology Technology Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Carl Zeiss Meditec AG
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Bausch + Lomb.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Teva Pharmaceutical Industries Ltd.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. CooperVision
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Alcon
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. NIDEK CO., LTD.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. TOPCON CORPORATION
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Ziemer Ophthalmic Systems AG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Essilor International S.A.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives